Background: To define parameters characterizing monoclonal antibody (mAb) agglutination properties is a topic of high relevance in diagnostic immunohematology. Material and Methods: Laser backscattering is used to analyze the agglutinates’ dissociation process. The suspension in a Couette flow is exposed to different shear forces, and the backscattering light intensity is quantified. Parameters characterizing antibody agglutination properties are obtained. Results: Parameters obtained by the rheo-optical method characterize antibodies agglutination properties. They are proportional to antibody concentration. The approaches allows to classify mAb according to the agglutination strength as high-, medium- and low-strength antibodies and were successfully applied to determine parameters for polyclonal (anti-A, anti-D) and monoclonal (anti-A, anti-B, anti-AB, anti-H, anti-Le, anti-P, anti-M, anti-N, anti-GPA and anti- T) antibodies. The first approach was also used to discriminate blood group A phenotypes. Estimation of the linear regression slope is an interesting parameter to evaluate the strength of the reaction which may depend on density of antigenic sites on the cell membrane but also on the specificity of the cell antigen. Conclusions: The biophysical approach presented in this work can provide new and interesting information about intercellular adhesion and, consequently, may suggest new questions on the energies involved in immunological red blood cell agglutination. Such information on the energy existing between membranes agglutinated by mAb may help to understand many important physiological and pathological phenomena, but, particularly, it will be useful in the quality control of monoclonal antibodies.

This content is only available via PDF.
© 2004 S. Karger GmbH, Freiburg
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.